Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
348,324
-
Share change
-
-1,376,685
-
Total reported value
-
$19,886,345
-
Price per share
-
$57.22
-
Number of holders
-
14
-
Value change
-
-$86,940,475
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of NOVOZYMES AS/FI - ADR (NVZMY) as of Q4 2020
As of 31 Dec 2020,
NOVOZYMES AS/FI - ADR (NVZMY) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
348,324 shares.
The largest 10 holders included
Parametric Portfolio Associates LLC, ZEVIN ASSET MANAGEMENT LLC, Douglass Winthrop Advisors, LLC, Hemenway Trust Co LLC, HIGH POINTE CAPITAL MANAGEMENT LLC, ST GERMAIN D J CO INC, Boston Common Asset Management, LLC, Moloney Securities Asset Management, LLC, PNC Financial Services Group, Inc., and CAPTRUST FINANCIAL ADVISORS.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.